Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Benjamin T. Ristau is a urologic oncologist and researcher whose work bridges cutting-edge biomedical technology with clinical urology. His primary research areas include organoid-based high-content screening, robotic surgery outcomes, and the management of urologic cancers such as bladder and endometrial carcinoma. Dr. Ristau’s most notable contribution is the development of an automated 3D high-content cell screening platform for organoid phenotyping (2024, 18 citations), a breakthrough that enables high-throughput, biologically relevant drug testing and disease modeling. This work addresses a critical need in precision medicine by expanding the utility of organoid systems. In clinical research, he led a multicenter study comparing functional outcomes of robotic versus open partial nephrectomy in patients with pre-existing chronic kidney disease (2018, 11 citations), providing evidence to guide surgical decision-making. He also reported the first case of metastatic serous endometrial carcinoma to the ureter (2021, 3 citations), highlighting rare disease presentations. Additionally, his investigation into indeterminate pulmonary nodules in bladder cancer patients undergoing radical cystectomy (2017, 2 citations) informs postoperative surveillance. Dr. Ristau’s work exemplifies the integration of innovative lab technologies with real-world patient care, advancing both fundamental understanding and clinical practice in urologic oncology.